Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant

The antigenic variation of influenza virus represents a major health problem, thus continuous efforts have been made to develop broad-spectrum vaccines against influenza virus. Matrix protein 1 (M1) protein is highly conserved in all influenza A strains. In this study, M1 protein was efficiently exp...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 28; no. 48; pp. 7690 - 7698
Main Authors Sui, Zhiwei, Chen, Quanjiao, Fang, Fang, Zheng, Mei, Chen, Ze
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 10.11.2010
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…